aluates Reports

$ 0.0

Automative

Global Circulating Tumor Cell Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-36G5969

Global Circulating Tumor Cell Market Insights Forecast to 2028

BUY CHAPTERS

Global Circulating Tumor Cell Market Research Report 2024

Code: QYRE-Auto-36G5969

Report

January 2024

Pages:106

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Circulating Tumor Cell Market Size

The global Circulating Tumor Cell market was valued at US$ 670.2 million in 2023 and is anticipated to reach US$ 1140.7 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.

Circulating Tumor Cell Market

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.

This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cell.

Report Scope

The Circulating Tumor Cell market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Tumor Cell market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Circulating Tumor Cell companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Circulating Tumor Cell Market Report

Report Metric	Details
Report Name	Circulating Tumor Cell Market
Accounted market size in 2023	US$ 670.2 million
Forecasted market size in 2030	US$ 1140.7 million
CAGR	7.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	CTC Enrichment CTC Detection CTC Analysis
Segment by Application	Breast Cancer Prostate Cancer Colorectal Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm, ApoCell, Greiner Bio-one, Advanced Cell Diagnostics, Aviva Biosciences, Fluxion Biosciences, Sysmex, Epic Sciences, Cynvenio, CytoTrack, Ikonisys, Vortex BioSciences, Gilupi, Biocept, ScreenCell, ANGLE
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cell companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Circulating Tumor Cell Market growing?

Ans: The Circulating Tumor Cell Market witnessing a CAGR of 7.9% during the forecast period 2024-2030.

What is the Circulating Tumor Cell Market size in 2030?

Ans: The Circulating Tumor Cell Market size in 2030 will be US$ 1140.7 million.

What is the market share of major companies in Circulating Tumor Cell Market?

Ans: Global top five manufacturers hold a share over 30%.

Who are the main players in the Circulating Tumor Cell Market report?

Ans: The main players in the Circulating Tumor Cell Market are Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm, ApoCell, Greiner Bio-one, Advanced Cell Diagnostics, Aviva Biosciences, Fluxion Biosciences, Sysmex, Epic Sciences, Cynvenio, CytoTrack, Ikonisys, Vortex BioSciences, Gilupi, Biocept, ScreenCell, ANGLE

What are the Application segmentation covered in the Circulating Tumor Cell Market report?

Ans: The Applications covered in the Circulating Tumor Cell Market report are Breast Cancer, Prostate Cancer, Colorectal Cancer, Others

What are the Type segmentation covered in the Circulating Tumor Cell Market report?

Ans: The Types covered in the Circulating Tumor Cell Market report are CTC Enrichment, CTC Detection, CTC Analysis

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Circulating Tumor Cell Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 CTC Enrichment

1.2.3 CTC Detection

1.2.4 CTC Analysis

1.3 Market by Application

1.3.1 Global Circulating Tumor Cell Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Breast Cancer

1.3.3 Prostate Cancer

1.3.4 Colorectal Cancer

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Circulating Tumor Cell Market Perspective (2019-2030)

2.2 Circulating Tumor Cell Growth Trends by Region

2.2.1 Global Circulating Tumor Cell Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Circulating Tumor Cell Historic Market Size by Region (2019-2024)

2.2.3 Circulating Tumor Cell Forecasted Market Size by Region (2025-2030)

2.3 Circulating Tumor Cell Market Dynamics

2.3.1 Circulating Tumor Cell Industry Trends

2.3.2 Circulating Tumor Cell Market Drivers

2.3.3 Circulating Tumor Cell Market Challenges

2.3.4 Circulating Tumor Cell Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Circulating Tumor Cell Players by Revenue

3.1.1 Global Top Circulating Tumor Cell Players by Revenue (2019-2024)

3.1.2 Global Circulating Tumor Cell Revenue Market Share by Players (2019-2024)

3.2 Global Circulating Tumor Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Circulating Tumor Cell Revenue

3.4 Global Circulating Tumor Cell Market Concentration Ratio

3.4.1 Global Circulating Tumor Cell Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Revenue in 2023

3.5 Circulating Tumor Cell Key Players Head office and Area Served

3.6 Key Players Circulating Tumor Cell Product Solution and Service

3.7 Date of Enter into Circulating Tumor Cell Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Circulating Tumor Cell Breakdown Data by Type

4.1 Global Circulating Tumor Cell Historic Market Size by Type (2019-2024)

4.2 Global Circulating Tumor Cell Forecasted Market Size by Type (2025-2030)

5 Circulating Tumor Cell Breakdown Data by Application

5.1 Global Circulating Tumor Cell Historic Market Size by Application (2019-2024)

5.2 Global Circulating Tumor Cell Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Circulating Tumor Cell Market Size (2019-2030)

6.2 North America Circulating Tumor Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Circulating Tumor Cell Market Size by Country (2019-2024)

6.4 North America Circulating Tumor Cell Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Circulating Tumor Cell Market Size (2019-2030)

7.2 Europe Circulating Tumor Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Circulating Tumor Cell Market Size by Country (2019-2024)

7.4 Europe Circulating Tumor Cell Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Circulating Tumor Cell Market Size (2019-2030)

8.2 Asia-Pacific Circulating Tumor Cell Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Circulating Tumor Cell Market Size by Region (2019-2024)

8.4 Asia-Pacific Circulating Tumor Cell Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Circulating Tumor Cell Market Size (2019-2030)

9.2 Latin America Circulating Tumor Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Circulating Tumor Cell Market Size by Country (2019-2024)

9.4 Latin America Circulating Tumor Cell Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Circulating Tumor Cell Market Size (2019-2030)

10.2 Middle East & Africa Circulating Tumor Cell Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Circulating Tumor Cell Market Size by Country (2019-2024)

10.4 Middle East & Africa Circulating Tumor Cell Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Menarini-Silicon Biosystems

11.1.1 Menarini-Silicon Biosystems Company Detail

11.1.2 Menarini-Silicon Biosystems Business Overview

11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cell Introduction

11.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2019-2024)

11.1.5 Menarini-Silicon Biosystems Recent Development

11.2 Qiagen（Adnagen）

11.2.1 Qiagen（Adnagen） Company Detail

11.2.2 Qiagen（Adnagen） Business Overview

11.2.3 Qiagen（Adnagen） Circulating Tumor Cell Introduction

11.2.4 Qiagen（Adnagen） Revenue in Circulating Tumor Cell Business (2019-2024)

11.2.5 Qiagen（Adnagen） Recent Development

11.3 Clearbridge Biomedics

11.3.1 Clearbridge Biomedics Company Detail

11.3.2 Clearbridge Biomedics Business Overview

11.3.3 Clearbridge Biomedics Circulating Tumor Cell Introduction

11.3.4 Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2019-2024)

11.3.5 Clearbridge Biomedics Recent Development

11.4 Celsee

11.4.1 Celsee Company Detail

11.4.2 Celsee Business Overview

11.4.3 Celsee Circulating Tumor Cell Introduction

11.4.4 Celsee Revenue in Circulating Tumor Cell Business (2019-2024)

11.4.5 Celsee Recent Development

11.5 Fluidigm

11.5.1 Fluidigm Company Detail

11.5.2 Fluidigm Business Overview

11.5.3 Fluidigm Circulating Tumor Cell Introduction

11.5.4 Fluidigm Revenue in Circulating Tumor Cell Business (2019-2024)

11.5.5 Fluidigm Recent Development

11.6 ApoCell

11.6.1 ApoCell Company Detail

11.6.2 ApoCell Business Overview

11.6.3 ApoCell Circulating Tumor Cell Introduction

11.6.4 ApoCell Revenue in Circulating Tumor Cell Business (2019-2024)

11.6.5 ApoCell Recent Development

11.7 Greiner Bio-one

11.7.1 Greiner Bio-one Company Detail

11.7.2 Greiner Bio-one Business Overview

11.7.3 Greiner Bio-one Circulating Tumor Cell Introduction

11.7.4 Greiner Bio-one Revenue in Circulating Tumor Cell Business (2019-2024)

11.7.5 Greiner Bio-one Recent Development

11.8 Advanced Cell Diagnostics

11.8.1 Advanced Cell Diagnostics Company Detail

11.8.2 Advanced Cell Diagnostics Business Overview

11.8.3 Advanced Cell Diagnostics Circulating Tumor Cell Introduction

11.8.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2019-2024)

11.8.5 Advanced Cell Diagnostics Recent Development

11.9 Aviva Biosciences

11.9.1 Aviva Biosciences Company Detail

11.9.2 Aviva Biosciences Business Overview

11.9.3 Aviva Biosciences Circulating Tumor Cell Introduction

11.9.4 Aviva Biosciences Revenue in Circulating Tumor Cell Business (2019-2024)

11.9.5 Aviva Biosciences Recent Development

11.10 Fluxion Biosciences

11.10.1 Fluxion Biosciences Company Detail

11.10.2 Fluxion Biosciences Business Overview

11.10.3 Fluxion Biosciences Circulating Tumor Cell Introduction

11.10.4 Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2019-2024)

11.10.5 Fluxion Biosciences Recent Development

11.11 Sysmex

11.11.1 Sysmex Company Detail

11.11.2 Sysmex Business Overview

11.11.3 Sysmex Circulating Tumor Cell Introduction

11.11.4 Sysmex Revenue in Circulating Tumor Cell Business (2019-2024)

11.11.5 Sysmex Recent Development

11.12 Epic Sciences

11.12.1 Epic Sciences Company Detail

11.12.2 Epic Sciences Business Overview

11.12.3 Epic Sciences Circulating Tumor Cell Introduction

11.12.4 Epic Sciences Revenue in Circulating Tumor Cell Business (2019-2024)

11.12.5 Epic Sciences Recent Development

11.13 Cynvenio

11.13.1 Cynvenio Company Detail

11.13.2 Cynvenio Business Overview

11.13.3 Cynvenio Circulating Tumor Cell Introduction

11.13.4 Cynvenio Revenue in Circulating Tumor Cell Business (2019-2024)

11.13.5 Cynvenio Recent Development

11.14 CytoTrack

11.14.1 CytoTrack Company Detail

11.14.2 CytoTrack Business Overview

11.14.3 CytoTrack Circulating Tumor Cell Introduction

11.14.4 CytoTrack Revenue in Circulating Tumor Cell Business (2019-2024)

11.14.5 CytoTrack Recent Development

11.15 Ikonisys

11.15.1 Ikonisys Company Detail

11.15.2 Ikonisys Business Overview

11.15.3 Ikonisys Circulating Tumor Cell Introduction

11.15.4 Ikonisys Revenue in Circulating Tumor Cell Business (2019-2024)

11.15.5 Ikonisys Recent Development

11.16 Vortex BioSciences

11.16.1 Vortex BioSciences Company Detail

11.16.2 Vortex BioSciences Business Overview

11.16.3 Vortex BioSciences Circulating Tumor Cell Introduction

11.16.4 Vortex BioSciences Revenue in Circulating Tumor Cell Business (2019-2024)

11.16.5 Vortex BioSciences Recent Development

11.17 Gilupi

11.17.1 Gilupi Company Detail

11.17.2 Gilupi Business Overview

11.17.3 Gilupi Circulating Tumor Cell Introduction

11.17.4 Gilupi Revenue in Circulating Tumor Cell Business (2019-2024)

11.17.5 Gilupi Recent Development

11.18 Biocept

11.18.1 Biocept Company Detail

11.18.2 Biocept Business Overview

11.18.3 Biocept Circulating Tumor Cell Introduction

11.18.4 Biocept Revenue in Circulating Tumor Cell Business (2019-2024)

11.18.5 Biocept Recent Development

11.19 ScreenCell

11.19.1 ScreenCell Company Detail

11.19.2 ScreenCell Business Overview

11.19.3 ScreenCell Circulating Tumor Cell Introduction

11.19.4 ScreenCell Revenue in Circulating Tumor Cell Business (2019-2024)

11.19.5 ScreenCell Recent Development

11.20 ANGLE

11.20.1 ANGLE Company Detail

11.20.2 ANGLE Business Overview

11.20.3 ANGLE Circulating Tumor Cell Introduction

11.20.4 ANGLE Revenue in Circulating Tumor Cell Business (2019-2024)

11.20.5 ANGLE Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Circulating Tumor Cell Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of CTC Enrichment

Table 3. Key Players of CTC Detection

Table 4. Key Players of CTC Analysis

Table 5. Global Circulating Tumor Cell Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Circulating Tumor Cell Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Circulating Tumor Cell Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Circulating Tumor Cell Market Share by Region (2019-2024)

Table 9. Global Circulating Tumor Cell Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Circulating Tumor Cell Market Share by Region (2025-2030)

Table 11. Circulating Tumor Cell Market Trends

Table 12. Circulating Tumor Cell Market Drivers

Table 13. Circulating Tumor Cell Market Challenges

Table 14. Circulating Tumor Cell Market Restraints

Table 15. Global Circulating Tumor Cell Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Circulating Tumor Cell Market Share by Players (2019-2024)

Table 17. Global Top Circulating Tumor Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell as of 2023)

Table 18. Ranking of Global Top Circulating Tumor Cell Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cell Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Circulating Tumor Cell Product Solution and Service

Table 22. Date of Enter into Circulating Tumor Cell Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Circulating Tumor Cell Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Circulating Tumor Cell Revenue Market Share by Type (2019-2024)

Table 26. Global Circulating Tumor Cell Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Circulating Tumor Cell Revenue Market Share by Type (2025-2030)

Table 28. Global Circulating Tumor Cell Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Circulating Tumor Cell Revenue Market Share by Application (2019-2024)

Table 30. Global Circulating Tumor Cell Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Circulating Tumor Cell Revenue Market Share by Application (2025-2030)

Table 32. North America Circulating Tumor Cell Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Circulating Tumor Cell Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Circulating Tumor Cell Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Circulating Tumor Cell Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Circulating Tumor Cell Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Circulating Tumor Cell Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Circulating Tumor Cell Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Circulating Tumor Cell Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Circulating Tumor Cell Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Circulating Tumor Cell Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Circulating Tumor Cell Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Circulating Tumor Cell Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Circulating Tumor Cell Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Circulating Tumor Cell Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Circulating Tumor Cell Market Size by Country (2025-2030) & (US$ Million)

Table 47. Menarini-Silicon Biosystems Company Detail

Table 48. Menarini-Silicon Biosystems Business Overview

Table 49. Menarini-Silicon Biosystems Circulating Tumor Cell Product

Table 50. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 51. Menarini-Silicon Biosystems Recent Development

Table 52. Qiagen（Adnagen） Company Detail

Table 53. Qiagen（Adnagen） Business Overview

Table 54. Qiagen（Adnagen） Circulating Tumor Cell Product

Table 55. Qiagen（Adnagen） Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 56. Qiagen（Adnagen） Recent Development

Table 57. Clearbridge Biomedics Company Detail

Table 58. Clearbridge Biomedics Business Overview

Table 59. Clearbridge Biomedics Circulating Tumor Cell Product

Table 60. Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 61. Clearbridge Biomedics Recent Development

Table 62. Celsee Company Detail

Table 63. Celsee Business Overview

Table 64. Celsee Circulating Tumor Cell Product

Table 65. Celsee Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 66. Celsee Recent Development

Table 67. Fluidigm Company Detail

Table 68. Fluidigm Business Overview

Table 69. Fluidigm Circulating Tumor Cell Product

Table 70. Fluidigm Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 71. Fluidigm Recent Development

Table 72. ApoCell Company Detail

Table 73. ApoCell Business Overview

Table 74. ApoCell Circulating Tumor Cell Product

Table 75. ApoCell Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 76. ApoCell Recent Development

Table 77. Greiner Bio-one Company Detail

Table 78. Greiner Bio-one Business Overview

Table 79. Greiner Bio-one Circulating Tumor Cell Product

Table 80. Greiner Bio-one Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 81. Greiner Bio-one Recent Development

Table 82. Advanced Cell Diagnostics Company Detail

Table 83. Advanced Cell Diagnostics Business Overview

Table 84. Advanced Cell Diagnostics Circulating Tumor Cell Product

Table 85. Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 86. Advanced Cell Diagnostics Recent Development

Table 87. Aviva Biosciences Company Detail

Table 88. Aviva Biosciences Business Overview

Table 89. Aviva Biosciences Circulating Tumor Cell Product

Table 90. Aviva Biosciences Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 91. Aviva Biosciences Recent Development

Table 92. Fluxion Biosciences Company Detail

Table 93. Fluxion Biosciences Business Overview

Table 94. Fluxion Biosciences Circulating Tumor Cell Product

Table 95. Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 96. Fluxion Biosciences Recent Development

Table 97. Sysmex Company Detail

Table 98. Sysmex Business Overview

Table 99. Sysmex Circulating Tumor Cell Product

Table 100. Sysmex Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 101. Sysmex Recent Development

Table 102. Epic Sciences Company Detail

Table 103. Epic Sciences Business Overview

Table 104. Epic Sciences Circulating Tumor Cell Product

Table 105. Epic Sciences Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 106. Epic Sciences Recent Development

Table 107. Cynvenio Company Detail

Table 108. Cynvenio Business Overview

Table 109. Cynvenio Circulating Tumor Cell Product

Table 110. Cynvenio Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 111. Cynvenio Recent Development

Table 112. CytoTrack Company Detail

Table 113. CytoTrack Business Overview

Table 114. CytoTrack Circulating Tumor Cell Product

Table 115. CytoTrack Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 116. CytoTrack Recent Development

Table 117. Ikonisys Company Detail

Table 118. Ikonisys Business Overview

Table 119. Ikonisys Circulating Tumor Cell Product

Table 120. Ikonisys Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 121. Ikonisys Recent Development

Table 122. Vortex BioSciences Company Detail

Table 123. Vortex BioSciences Business Overview

Table 124. Vortex BioSciences Circulating Tumor Cell Product

Table 125. Vortex BioSciences Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 126. Vortex BioSciences Recent Development

Table 127. Gilupi Company Detail

Table 128. Gilupi Business Overview

Table 129. Gilupi Circulating Tumor Cell Product

Table 130. Gilupi Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 131. Gilupi Recent Development

Table 132. Biocept Company Detail

Table 133. Biocept Business Overview

Table 134. Biocept Circulating Tumor Cell Product

Table 135. Biocept Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 136. Biocept Recent Development

Table 137. ScreenCell Company Detail

Table 138. ScreenCell Business Overview

Table 139. ScreenCell Circulating Tumor Cell Product

Table 140. ScreenCell Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 141. ScreenCell Recent Development

Table 142. ANGLE Company Detail

Table 143. ANGLE Business Overview

Table 144. ANGLE Circulating Tumor Cell Product

Table 145. ANGLE Revenue in Circulating Tumor Cell Business (2019-2024) & (US$ Million)

Table 146. ANGLE Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Circulating Tumor Cell Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Circulating Tumor Cell Market Share by Type: 2023 VS 2030

Figure 3. CTC Enrichment Features

Figure 4. CTC Detection Features

Figure 5. CTC Analysis Features

Figure 6. Global Circulating Tumor Cell Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Circulating Tumor Cell Market Share by Application: 2023 VS 2030

Figure 8. Breast Cancer Case Studies

Figure 9. Prostate Cancer Case Studies

Figure 10. Colorectal Cancer Case Studies

Figure 11. Others Case Studies

Figure 12. Circulating Tumor Cell Report Years Considered

Figure 13. Global Circulating Tumor Cell Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Circulating Tumor Cell Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Circulating Tumor Cell Market Share by Region: 2023 VS 2030

Figure 16. Global Circulating Tumor Cell Market Share by Players in 2023

Figure 17. Global Top Circulating Tumor Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Circulating Tumor Cell Revenue in 2023

Figure 19. North America Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Circulating Tumor Cell Market Share by Country (2019-2030)

Figure 21. United States Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Circulating Tumor Cell Market Share by Country (2019-2030)

Figure 25. Germany Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Circulating Tumor Cell Market Share by Region (2019-2030)

Figure 33. China Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Circulating Tumor Cell Market Share by Country (2019-2030)

Figure 41. Mexico Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Circulating Tumor Cell Market Share by Country (2019-2030)

Figure 45. Turkey Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Circulating Tumor Cell Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 48. Qiagen（Adnagen） Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 49. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 50. Celsee Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 51. Fluidigm Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 52. ApoCell Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 53. Greiner Bio-one Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 54. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 55. Aviva Biosciences Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 56. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 57. Sysmex Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 58. Epic Sciences Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 59. Cynvenio Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 60. CytoTrack Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 61. Ikonisys Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 62. Vortex BioSciences Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 63. Gilupi Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 64. Biocept Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 65. ScreenCell Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 66. ANGLE Revenue Growth Rate in Circulating Tumor Cell Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-8R13419

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Gastrointestinal Cancer Devices Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-22Z6784

Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Laser Blood Irradiation Therapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3T15192

Thu May 16 00:00:00 UTC 2024

Add to Cart

Global Tumor Embolization Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31S11385

Mon May 06 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Circulating Tumor Cell Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-36G5969

Global Circulating Tumor Cell Market Research Report 2024

FEATURED COMPANIES

Circulating Tumor Cell Market Size

Circulating Tumor Cell Market

Report Scope

Scope of Circulating Tumor Cell Market Report

Chapter Outline

FAQ for this report

How fast is Circulating Tumor Cell Market growing?

What is the Circulating Tumor Cell Market size in 2030?

What is the market share of major companies in Circulating Tumor Cell Market?

Who are the main players in the Circulating Tumor Cell Market report?

What are the Application segmentation covered in the Circulating Tumor Cell Market report?

What are the Type segmentation covered in the Circulating Tumor Cell Market report?

FEATURED COMPANIES

RELATED REPORTS